Jeddah, Makkah, Saudi Arabia
With over 8 years of experience in pharmaceutical research and development, currently serving as Supervisor of Formulation Development and Stability at PSI. Specializes in formulation development and technology transfer of injectable, IV infusion, and ophthalmic products. Expertise in Good Manufacturing Practices (GMP), cross-functional team leadership, and compliance with cGMP regulations. Contributes to the seamless transition of products from R&D to commercial manufacturing, ensuring production readiness and regulatory compliance. Committed to advancing pharmaceutical processes through collaboration and optimized product development to deliver high-quality therapeutic solutions.
Spearheaded the tech transfer of 4 generic products with 100% compliance and zero deviations. Resolved formulation and process-related issues using root cause analysis, minimizing production downtime. Extended the shelf life of two products by 12 months through improved ICH-aligned stability design. Mentored junior staff on QbD, regulatory expectations, and product development.
Executed process optimization projects that reduced batch failures, including solving a critical sticking issue in a highly adhesive product Led successful scale-up of 3 oral dosage forms, improving yield by 15% Delivered cross-departmental training for over 10 staff members on GMP practices and tech transfer tools
Managed generic product development, preclinical, and stability programs. Coordinated with CDMOs and internal teams for scale-up, registration, and manufacturing readiness. Authored technical documentation for product registration.
Assistant in practical’s and tutorial in pharmaceutical Science lab at the school of health science.